CDKN1A and cancer: It was shown that LNCaP cells had higher cyclin‐dependent kinase inhibitor 1A (CDKN1A) expression and lower 3‐phosphoinositide‐dependent kinase 1 (PDK1) expression, both of which have been connected to the development of cancer.